|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Merchandise Inventories, Net | ||||||||||||||||||||
| Prepaid Expenses | ||||||||||||||||||||
| Tariff Recovery Receivable | ||||||||||||||||||||
| Other Current Assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and Equipment, Net | ||||||||||||||||||||
| Operating Lease Right-of-Use Assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred Tax Assets, Net | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts Payable | ||||||||||||||||||||
| Customer Deposits and Store Credits | ||||||||||||||||||||
| Accrued Compensation | ||||||||||||||||||||
| Sales and Income Tax Liabilities | ||||||||||||||||||||
| Accrual for Legal Matters and Settlements - Current | ||||||||||||||||||||
| Operating Lease Liabilities - Current | ||||||||||||||||||||
| Other Current Liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Other Long-Term Liabilities | ||||||||||||||||||||
| Operating Lease Liabilities - Long-Term | ||||||||||||||||||||
| Credit Agreement | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||||
| Common Stock ($0.001 par value; 35,000 shares authorized; 31,389 and 30,983 shares issued and 29,118 and 28,849 shares outstanding at March 31, 2024 and December 31, 2023, respectively) | ||||||||||||||||||||
| Treasury Stock, at cost (2,271 and 2,134 shares, respectively) | ||||||||||||||||||||
| Additional Capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
Loading...
